These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 14766023

  • 1. Magnetism and cardiac arrhythmias.
    Scherlag BJ, Yamanashi WS, Hou Y, Jacobson JI, Jackman WM, Lazzara R.
    Cardiol Rev; 2004; 12(2):85-96. PubMed ID: 14766023
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Focal pharmacological modulation of atrioventricular nodal conduction via implantable catheter: a novel therapy for atrial fibrillation?
    Sigg DC, Hiniduma-Lokuge P, Coles JA, Falkner P, Rose R, Urban JF, Ujhelyi MR.
    Circulation; 2006 May 23; 113(20):2383-90. PubMed ID: 16702470
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The use of low-level electromagnetic fields to suppress atrial fibrillation.
    Yu L, Dyer JW, Scherlag BJ, Stavrakis S, Sha Y, Sheng X, Garabelli P, Jacobson J, Po SS.
    Heart Rhythm; 2015 Apr 23; 12(4):809-17. PubMed ID: 25533588
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of transforming growth factor-beta1 on atrioventricular node conduction modification by injected autologous fibroblasts in the canine heart.
    Bunch TJ, Mahapatra S, Bruce GK, Johnson SB, Miller DV, Horne BD, Wang XL, Lee HC, Caplice NM, Packer DL.
    Circulation; 2006 May 30; 113(21):2485-94. PubMed ID: 16717152
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Targeting of cardiac autonomic plexus for modulation of intracardiac neural tone.
    Gemein C, Schauerte P, Hatam N, Rana OR, Saygili E, Meyer C, Eickholt C, Schmid M, Knackstedt C, Zarse M, Mischke K.
    Europace; 2009 Aug 30; 11(8):1090-6. PubMed ID: 19561039
    [Abstract] [Full Text] [Related]

  • 14. [Influence of the autonomic nervous system on the normal and pathological atrioventricular node].
    Victor J, Foussard C, Laporte J, Bouvier JM, Tadei A.
    Arch Mal Coeur Vaiss; 1987 Sep 30; 80(10):1471-7. PubMed ID: 3125807
    [Abstract] [Full Text] [Related]

  • 15. Effects of autonomic activity and changes in heart rate on atrioventricular conduction.
    Wallick DW, Martin PJ, Masuda Y, Levy MN.
    Am J Physiol; 1982 Oct 30; 243(4):H523-7. PubMed ID: 7124960
    [Abstract] [Full Text] [Related]

  • 16. Heart rate variability in patients suffering from structural heart disease and decreased AV-nodal conduction capacity. Insights into the formation of heart rate variability.
    Schwab JO, Eichner G, Schmitt H, Schrickel J, Yang A, Balta O, Lüderitz B, Lewalter T.
    Z Kardiol; 2004 Mar 30; 93(3):229-33. PubMed ID: 15024591
    [Abstract] [Full Text] [Related]

  • 17. Cardiac electrical stunning is a common feature of cardiac arrhythmias.
    Li G, Liu T, Liu E.
    Med Hypotheses; 2006 Mar 30; 67(4):865-7. PubMed ID: 16759818
    [Abstract] [Full Text] [Related]

  • 18. [Effects of the length of the stimulation cycle and of autonomic block on the refractory periods of the atrioventricular node].
    Valentín Segura V, Chorro Gasco J, Such Belenguer L, Ferrero Cabedo JA, López Merino V, Viña Giner J.
    Rev Esp Cardiol; 1984 Mar 30; 37(5):330-5. PubMed ID: 6494542
    [No Abstract] [Full Text] [Related]

  • 19. An experimental study on canine A-V junctional pacemaker--evaluation of the automaticity by overdrive suppression and autonomic blockade by practolol and atropine.
    Tanahashi Y.
    Jpn Circ J; 1977 Sep 30; 41(9):1037-9, 1043-9. PubMed ID: 916152
    [Abstract] [Full Text] [Related]

  • 20. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs.
    Shiroshita-Takeshita A, Sakabe M, Haugan K, Hennan JK, Nattel S.
    Circulation; 2007 Jan 23; 115(3):310-8. PubMed ID: 17224477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.